US Stock MarketDetailed Quotes

TMO Thermo Fisher Scientific

Watchlist

526.070
-1.110-0.21%

Close Dec 27 16:00 ET

526.070
0.0000.00%

Post 20:01 ET

201.22BMarket Cap32.98P/E (TTM)

Thermo Fisher Scientific Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 29, 2024

(Q1)Mar 30, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jul 1, 2023

(Q1)Apr 1, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-10.40%2.16B

27.47%1.96B

71.47%1.25B

-8.17%8.41B

6.77%3.72B

24.63%2.41B

0.79%1.54B

-66.89%729M

-1.70%9.15B

41.92%3.49B

Net income from continuing operations

-3.89%1.63B

14.10%1.55B

3.02%1.33B

-14.44%5.96B

2.03%1.61B

13.15%1.7B

-18.35%1.36B

-41.80%1.29B

-9.94%6.96B

-5.12%1.57B

Operating gains losses

----

-96.61%26M

--0

Depreciation and amortization

-13.36%739M

-7.49%791M

-2.68%836M

0.74%3.41B

-1.06%839M

1.79%853M

2.27%855M

0.00%859M

30.44%3.38B

24.16%848M

Deferred tax

-32.01%-400M

-94.51%-354M

-73.29%-253M

-30.65%-1.3B

-403.01%-669M

-16.09%-303M

30.53%-182M

56.93%-146M

-53.79%-995M

30.73%-133M

Other non cash items

-9.91%100M

-32.21%101M

-70.17%54M

16.36%562M

202.50%121M

-26.97%111M

156.90%149M

-22.32%181M

209.62%483M

211.11%40M

Change In working capital

433.33%30M

69.92%-216M

48.66%-787M

50.89%-495M

62.97%1.77B

97.55%-9M

15.43%-718M

-75.20%-1.53B

33.42%-1.01B

456.25%1.08B

-Change in receivables

----

126.66%209M

----

-4,711.76%-784M

----

-Change in inventory

----

172.48%598M

----

22.54%-825M

----

-Change in payables and accrued expense

----

-177.16%-500M

----

35.28%648M

----

-Change in other working capital

----

-1,606.38%-802M

----

95.03%-47M

----

Cash from discontinued investing activities

Operating cash flow

-10.27%2.17B

27.27%1.96B

71.60%1.25B

-8.17%8.41B

6.77%3.72B

24.63%2.41B

0.79%1.54B

-66.89%729M

-1.70%9.15B

41.92%3.49B

Investing cash flow

Cash flow from continuing investing activities

-202.88%-3.58B

42.89%-253M

35.39%-2.03B

-138.17%-5.14B

28.38%-376M

-116.70%-1.18B

-5.73%-443M

-368.96%-3.14B

90.16%-2.16B

97.19%-525M

Net PPE purchase and sale

5.26%-252M

-1.79%-285M

24.12%-343M

37.27%-1.39B

27.57%-394M

51.01%-266M

43.32%-280M

29.15%-452M

11.35%-2.22B

33.66%-544M

Net business purchase and sale

-244.55%-3.13B

--0

-9,284.62%-3.66B

--0

-91,000.00%-909M

---47M

-6,660.00%-2.7B

99.80%-39M

--0

Net investment purchase and sale

-1,672.73%-195M

117.65%27M

---1.69B

366.67%70M

--234M

---11M

---153M

--0

87.50%15M

----

Net other investing changes

-80.00%1M

-86.49%5M

-50.00%7M

-290.48%-160M

-5,500.00%-216M

266.67%5M

-50.67%37M

75.00%14M

300.00%84M

200.00%4M

Cash from discontinued investing activities

Investing cash flow

-202.96%-3.58B

42.89%-253M

35.39%-2.03B

-138.17%-5.14B

28.38%-376M

-116.70%-1.18B

-5.73%-443M

-368.96%-3.14B

90.16%-2.16B

97.19%-525M

Financing cash flow

Cash flow from continuing financing activities

-164.15%-1.19B

92.10%-115M

29.81%-1.82B

-28.90%-3.62B

-159.72%-1.43B

1,328.48%1.86B

23.57%-1.46B

17.55%-2.59B

-142.70%-2.81B

-71.76%2.39B

Net issuance payments of debt

-156.14%-1.11B

99.92%-1M

139.09%1.21B

-123.70%-155M

-137.44%-1.31B

197,300.00%1.97B

27.40%-1.33B

150.00%504M

-92.66%654M

-59.40%3.49B

Net common stock issuance

--0

0.00%-3B

--0

-50.00%-3B

---1B

Cash dividends paid

-11.11%-150M

-10.37%-149M

-15.38%-135M

-14.95%-523M

-16.24%-136M

-14.41%-135M

-15.38%-135M

-13.59%-117M

-15.19%-455M

-13.59%-117M

Net other financing activities

272.22%67M

775.00%35M

445.00%109M

722.22%56M

-30.00%14M

156.25%18M

-89.19%4M

158.82%20M

-113.85%-9M

-74.68%20M

Cash from discontinued financing activities

Financing cash flow

-164.15%-1.19B

92.10%-115M

29.77%-1.82B

-28.90%-3.62B

-159.72%-1.43B

1,328.48%1.86B

23.57%-1.46B

17.55%-2.59B

-142.70%-2.81B

-71.76%2.39B

Net cash flow

Beginning cash position

125.09%7.1B

57.69%5.52B

-5.15%8.1B

90.09%8.54B

110.22%6.17B

65.51%3.15B

25.94%3.5B

90.09%8.54B

-56.55%4.49B

-75.65%2.93B

Current changes in cash

-184.26%-2.6B

543.73%1.59B

48.06%-2.6B

-108.55%-358M

-64.15%1.92B

148.83%3.09B

54.90%-359M

-210.35%-5.01B

169.30%4.19B

168.91%5.35B

Effect of exchange rate changes

339.73%175M

-225.00%-15M

170.97%22M

41.01%-82M

-96.00%10M

65.57%-73M

115.38%12M

68.69%-31M

-171.65%-139M

18.48%250M

End cash Position

-24.29%4.67B

125.09%7.1B

57.69%5.52B

-5.15%8.1B

110.22%6.17B

65.51%3.15B

25.94%3.5B

90.09%8.54B

Free cash flow

-9.03%1.89B

32.09%1.66B

233.58%904M

0.23%6.93B

12.97%3.32B

49.78%2.08B

22.90%1.26B

-82.65%271M

1.80%6.91B

80.63%2.94B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 29, 2024	(Q1)Mar 30, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jul 1, 2023	(Q1)Apr 1, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-10.40%2.16B	27.47%1.96B	71.47%1.25B	-8.17%8.41B	6.77%3.72B	24.63%2.41B	0.79%1.54B	-66.89%729M	-1.70%9.15B	41.92%3.49B
Net income from continuing operations	-3.89%1.63B	14.10%1.55B	3.02%1.33B	-14.44%5.96B	2.03%1.61B	13.15%1.7B	-18.35%1.36B	-41.80%1.29B	-9.94%6.96B	-5.12%1.57B
Operating gains losses	----	----	----	----	----	----	----	----	-96.61%26M	--0
Depreciation and amortization	-13.36%739M	-7.49%791M	-2.68%836M	0.74%3.41B	-1.06%839M	1.79%853M	2.27%855M	0.00%859M	30.44%3.38B	24.16%848M
Deferred tax	-32.01%-400M	-94.51%-354M	-73.29%-253M	-30.65%-1.3B	-403.01%-669M	-16.09%-303M	30.53%-182M	56.93%-146M	-53.79%-995M	30.73%-133M
Other non cash items	-9.91%100M	-32.21%101M	-70.17%54M	16.36%562M	202.50%121M	-26.97%111M	156.90%149M	-22.32%181M	209.62%483M	211.11%40M
Change In working capital	433.33%30M	69.92%-216M	48.66%-787M	50.89%-495M	62.97%1.77B	97.55%-9M	15.43%-718M	-75.20%-1.53B	33.42%-1.01B	456.25%1.08B
-Change in receivables	----	----	----	126.66%209M	----	----	----	----	-4,711.76%-784M	----
-Change in inventory	----	----	----	172.48%598M	----	----	----	----	22.54%-825M	----
-Change in payables and accrued expense	----	----	----	-177.16%-500M	----	----	----	----	35.28%648M	----
-Change in other working capital	----	----	----	-1,606.38%-802M	----	----	----	----	95.03%-47M	----
Cash from discontinued investing activities
Operating cash flow	-10.27%2.17B	27.27%1.96B	71.60%1.25B	-8.17%8.41B	6.77%3.72B	24.63%2.41B	0.79%1.54B	-66.89%729M	-1.70%9.15B	41.92%3.49B
Investing cash flow
Cash flow from continuing investing activities	-202.88%-3.58B	42.89%-253M	35.39%-2.03B	-138.17%-5.14B	28.38%-376M	-116.70%-1.18B	-5.73%-443M	-368.96%-3.14B	90.16%-2.16B	97.19%-525M
Net PPE purchase and sale	5.26%-252M	-1.79%-285M	24.12%-343M	37.27%-1.39B	27.57%-394M	51.01%-266M	43.32%-280M	29.15%-452M	11.35%-2.22B	33.66%-544M
Net business purchase and sale	-244.55%-3.13B	--0	--0	-9,284.62%-3.66B	--0	-91,000.00%-909M	---47M	-6,660.00%-2.7B	99.80%-39M	--0
Net investment purchase and sale	-1,672.73%-195M	117.65%27M	---1.69B	366.67%70M	--234M	---11M	---153M	--0	87.50%15M	----
Net other investing changes	-80.00%1M	-86.49%5M	-50.00%7M	-290.48%-160M	-5,500.00%-216M	266.67%5M	-50.67%37M	75.00%14M	300.00%84M	200.00%4M
Cash from discontinued investing activities
Investing cash flow	-202.96%-3.58B	42.89%-253M	35.39%-2.03B	-138.17%-5.14B	28.38%-376M	-116.70%-1.18B	-5.73%-443M	-368.96%-3.14B	90.16%-2.16B	97.19%-525M
Financing cash flow
Cash flow from continuing financing activities	-164.15%-1.19B	92.10%-115M	29.81%-1.82B	-28.90%-3.62B	-159.72%-1.43B	1,328.48%1.86B	23.57%-1.46B	17.55%-2.59B	-142.70%-2.81B	-71.76%2.39B
Net issuance payments of debt	-156.14%-1.11B	99.92%-1M	139.09%1.21B	-123.70%-155M	-137.44%-1.31B	197,300.00%1.97B	27.40%-1.33B	150.00%504M	-92.66%654M	-59.40%3.49B
Net common stock issuance	--0	--0	0.00%-3B	0.00%-3B	--0	--0	--0	-50.00%-3B	-50.00%-3B	---1B
Cash dividends paid	-11.11%-150M	-10.37%-149M	-15.38%-135M	-14.95%-523M	-16.24%-136M	-14.41%-135M	-15.38%-135M	-13.59%-117M	-15.19%-455M	-13.59%-117M
Net other financing activities	272.22%67M	775.00%35M	445.00%109M	722.22%56M	-30.00%14M	156.25%18M	-89.19%4M	158.82%20M	-113.85%-9M	-74.68%20M
Cash from discontinued financing activities
Financing cash flow	-164.15%-1.19B	92.10%-115M	29.77%-1.82B	-28.90%-3.62B	-159.72%-1.43B	1,328.48%1.86B	23.57%-1.46B	17.55%-2.59B	-142.70%-2.81B	-71.76%2.39B
Net cash flow
Beginning cash position	125.09%7.1B	57.69%5.52B	-5.15%8.1B	90.09%8.54B	110.22%6.17B	65.51%3.15B	25.94%3.5B	90.09%8.54B	-56.55%4.49B	-75.65%2.93B
Current changes in cash	-184.26%-2.6B	543.73%1.59B	48.06%-2.6B	-108.55%-358M	-64.15%1.92B	148.83%3.09B	54.90%-359M	-210.35%-5.01B	169.30%4.19B	168.91%5.35B
Effect of exchange rate changes	339.73%175M	-225.00%-15M	170.97%22M	41.01%-82M	-96.00%10M	65.57%-73M	115.38%12M	68.69%-31M	-171.65%-139M	18.48%250M
End cash Position	-24.29%4.67B	125.09%7.1B	57.69%5.52B	-5.15%8.1B	-5.15%8.1B	110.22%6.17B	65.51%3.15B	25.94%3.5B	90.09%8.54B	90.09%8.54B
Free cash flow	-9.03%1.89B	32.09%1.66B	233.58%904M	0.23%6.93B	12.97%3.32B	49.78%2.08B	22.90%1.26B	-82.65%271M	1.80%6.91B	80.63%2.94B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data